跳至主要内容
临床试验/ACTRN12612000957897
ACTRN12612000957897尚未招募2 期

Exenatide in acute ischemic stroke - a randomised controlled trial to look at its effect on post-stroke hyperglycemia, final infarct size and recanalisation and clinical outcome at 3 months

Monash University eastern clinical research unit0 个研究点目标入组 50 人开始时间: 2012年9月6日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • Age 18-90 years
  • Stroke symptom onset within 9 hours
  • Measurable NIHSS of 4-22
  • Blood sugar level on admission less than or equal to 3mmol/L
  • Pre-morbid modified Rankin Scale (mRS) score of 0-2
  • CT Brain has excluded intracerebral haemorrhage

排除标准

  • Unlikely to survive beyond 14 days
  • Have a known allergy or hypersensitivity to exenatide
  • Pregnant (known or suspected) or breast feeding
  • Diabetic patients already on exenatide, or combination insulin and oral hypoglycaemic agents
  • Past history of pancreatitis or evidence of active pancreatitis
  • Patients with other severe gastrointestinal disease like gastroparesis and dumping syndrome
  • Patients with end stage renal disease (creatinine clearance < 30 ml/min)

研究者

发起方
Monash University eastern clinical research unit

相似试验